- In Time for Holidays: More Gloom and Doom on Economy
- Turkey Day 101: How Well Do You Know Your Bird?
- US Home Prices Up 5th Month, 2nd Straight Quarter
- Holiday Guide to This Season's Smartphones
- Six Ways to Boost Your Income in a Big Way
- Buyers Look for Bargains at Luxury Condo Auction
- Ron Paul's Plan to Audit Fed a 'Serious Attack': Mishkin
- GM's Agreement to Sell Saab Unit Falls Apart
- Strong Banks, Weak Credit: Treasury Rethinks TARP
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- 3D's Tipping Point and Your Living Room
- On Twitter, Beware False Prophets
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Novartis 'Cells' Its Flu Vaccine Technology
- Silicon Valley and Hollywood Now Fast Friends
- Markets Can Rise 5-10% in the Near-Term: Strategist
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- GM's Agreement to Sell Saab To Swedish Firm Falls Apart
- US Home Prices Up 5th Month, 2nd Straight Quarter
- Buyers Look For Bargains At Luxury Condo Auction
- FDIC Fund Falls into The Red, Bair Urges Lending
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- Behind The Scenes With Warren Buffett
- 10 Holiday Cocktail Recipes from Top Mixologists
- CA "More Profitable" After Saving Energy: CEO
- The L.A. Extravaganza: A Test for Auto Shows
Text Size 
Stocks declined Wednesday, despite a rise in durable-goods orders and some earnings beats, as worries about the recovery dragged on the market.
And, the data today backed up those fears: New home-sales dropped 3.6 percent in September and August's gain was revised lower. Economists had expected sales to rise. That piled on to the bad news for the housing sector after an earlier report showed mortgage applications fall for the third week in a row last week.
And Goldman Sachs slashed its forecast for third-quarter GDP to 2.7 percent from 3 percent. The government's first read on Q3 GDP is due out on Thursday.
Investors shrugged off a report that showed durable-goods orders rose 1 percent in September, though compared to last year fell more than 24 percent.
Slow growth seemed to be the theme of the day, with the market nursing a hangover from a consumer confidence report Tuesday that also sounded the theme of economic fragility. Tech and consumer-discretionary stocks were among the hardest hit in yesterday's session.
The tech-heavy Nasdaq is now lower for October, though the Dow and S&P 500 are still higher for the month.
In early trading, Alcoa, JPMorgan and Bank of America were the biggest drags on the Dow. Telecoms AT&T and Verizon were at the top of the pack.
Oil fell, trading below $79 a barrel, after a report showed crude inventories rose by just 778,000 barrels last week. Economists had expected a 1.7 million build.
On the earnings front, ConocoPhillips [AIG
Loading...
()
] reported a sharp drop in earnings and revenue from a year earlier but still beat expectations.
This came after Visa [AIG
Loading...
()
] beat on both earnings and revenue with its results after the bell Tuesday, and raised its dividend.
Financials will be back in focus as an executive-compensation hearing kicks off today at 11am. Pay czar Kenneth Feinberg is expected to testify before the House Oversight Committee on the compensation decisions he's made regarding the seven companies under his jurisdiction — AIG [AIG
Loading...
()
] , Bank of America [BAC
Loading...
()
] , Citigroup [C
Loading...
()
] , Chrysler, Chrysler Financial, General Motors, and GMAC.
A tale of two IPOs today: Vitamin Shoppe shares [VSI
Loading...
()
] soared after the vitamin chain's IPO priced above expectations. It was the first retailer to go public in two years. Addus Homecare [ADUS
Loading...
()
] fell in its debut on the Nasdaq after pricing below expectations.
Apollo Group dragged on the Nasdaq, tumbling more than 15 percent, as federal regulators opened a probe into the educational group's accounting and at least three brokerages downgraded the stock.
Elsewhere, the Treasury continues its record week of auctions with the sale of $41 billion in 5-year notes. Yesterday's sale of 2-year notes saw extremely strong demand; today's auction comes at 1 pm.
There will be a fresh update on the health of the auto industry in general and General Motors in particular today, when Susan Docherty, the company's new VP of U.S. Sales, holds a conference call. That comes just a few days before the automakers release their October sales figures.
AstraZeneca [AZN-LN Loading... ()] could be a stock to watch as the company pulled its experimental lung cancer drug Zactima from the regulatory submission process, after the drug demonstrated no survival advantage when added to chemotherapy.
- Peter Schacknow contributed to this article.
Still to Come:
WEDNESDAY: Executive-compensation hearing; Yahoo analyst meeting
THURSDAY: 80th anniversary of 1929 market crash; Weekly jobless claims; first look at Q3 GDP; Larry Summers speaks in NYC; Earnings from AstraZeneca, ExxonMobil, P&G, Aetna, Kellogg, Motorola and Sprint Nextel
FRIDAY: Personal income and spending; consumer sentiment; Earnings from Chevron
Send comments to .
- Remember when auto shows were major events where new models could generate buzz?
- A diet high in fat and sugar might actually be good for your portfolio.
- A new McDonald's in Manhattan is the nation's first to sport a sleek, chic interior imported from stores in London and Paris.
- Italians were outraged by a minister's comments that lunchbreaks are bad for waistlines and the economy.
- Playboy will outsource its publishing operations in a bid to become profitable again.
- For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.
Data is a real-time snapshot *Data is delayed at least 15 minutes